Reported about 19 hours ago
BMO Capital has reduced its price target for Salesforce (NYSE:CRM) from $350 to $335 but continues to rate it as Outperform. Analyst Keith Bachman noted concerns about the adoption pace of Salesforce's newer initiatives despite positive feedback. He emphasized that translating innovation into revenue can take time, urging investors to focus on the company's long-term potential. While Salesforce shares have remained stable, the adjusted price target reflects short-term caution without changing the overall positive outlook on the company's strategic direction.
Source: YAHOO